Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,182 | Dovepress* | 9,751+ | 1,482 | 11,233 | |
| PubMed Central* | 2,431 | 539 | 2,970 | ||
| Totals | 12,182 | 2,021 | 14,203 | ||
| *Since 19 December 2018 | |||||
View citations on PubMed Central and Google Scholar